San Diego company’s test to detect pancreatic cancer in early stages moves to human trials

  • 📰 sdut
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 95%

España Noticias Noticias

España Últimas Noticias,España Titulares

Biological Dynamics spent more than a decade validating cancer diagnostic process spun out of UC San Diego and now has launched a study for people at high risk of pancreatic cancer

For more than a decade, Biological Dynamics has been working on technology licensed out of UC San Diego to enable early detection of diseases ranging from cancer to tuberculous to Alzheimer’s.

Founded in 2009, Biological Dynamics has developed proprietary technology that repels red blood cells and platelets to exclusively isolate exosomes — which are tiny structures inside a cell that contain some of the cell’s proteins, DNA and RNA. The lab-on-a-chip then detects the concentration of a handful of individual bio-markers specific to pancreatic cancer.

The company has raised $125 million since its founding to refine the technology. Biological Dynamics has 49 patents either granted or pending around its UCSD technology license.

 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 5. in ES

España Últimas Noticias, España Titulares